Semaglutide Pill Falls Short in Alzheimer's Battle
A recent study has brought disappointing news for those hoping to combat Alzheimer's disease. The drug semaglutide, known for its effectiveness in managing diabetes and obesity, did not show any significant benefits in slowing down the progression of Alzheimer's. This was revealed in two large-scale trials involving over 3, 800 participants who were already receiving...